A “new” proposal by the Biden administration to create a health-focused federal agency modeled after DARPA is not what it appears to be. Promoted as a way to “end cancer,” this resuscitated “health DARPA” conceals a dangerous agenda.
Last Wednesday, President Biden was widely praised in mainstream and health-care–focused media for his call to create a “new biomedical research agency” modeled after the US military’s “high-risk, high-reward” Defense Advanced Research Projects Agency, or DARPA. As touted by the president, the agency would seek to develop “innovative” and “breakthrough” treatments for cancer, Alzheimer’s disease, and diabetes, with a call to “end cancer as we know it.”
Far from “ending cancer” in the way most Americans might envision it, the proposed agency would merge “national security” with “health security” in such as way as to use both physical and mental health “warning signs” to prevent outbreaks of disease or violence before they occur. Such a system is a recipe for a technocratic “pre-crime” organization with the potential to criminalize both mental and physical illness as well as “wrongthink.”
The Biden administration has asked Congress for $6.5 billion to fund the agency, which would be largely guided by Biden’s recently confirmed top science adviser, Eric Lander. Lander, formerly the head of the Silicon Valley–dominated Broad Institute, has been controversial for his ties to eugenicist and child sex trafficker Jeffrey Epstein and his relatively recent praise for James Watson, an overtly racist eugenicist. Despite that, Lander is set to be confirmed by the Senate and Congress and is reportedly significantly enthusiastic about the proposed new “health DARPA.”
This new agency, set to be called ARPA-H or HARPA, would be housed within the National Institutes of Health (NIH) and would raise the NIH budget to over $51 billion. Unlike other agencies at NIH, ARPA-H would differ in that the projects it funds would not be peer reviewed prior to approval; instead hand-picked program managers would make all funding decisions. Funding would also take the form of milestone-driven payments instead of the more traditional multiyear grants.
ARPA-H will likely heavily fund and promote mRNA vaccines as one of the “breakthroughs” that will cure cancer. Some of the mRNA vaccine manufacturers that have produced some of the most widely used COVID-19 vaccines, such as the Pfizer/BioNTech vaccine, stated just last month that “cancer is the next problem to tackle with mRNA tech” post-COVID. BioNTech has been developing mRNA gene therapies for cancer for years and is collaborating with the Bill & Melinda Gates Foundation to create mRNA-based treatments for tuberculosis and HIV.
Other “innovative” technologies that will be a focus of this agency are less well known to the public and arguably more concerning.
The Long Road to ARPA-H
ARPA-H is not a new and exclusive Biden administration idea; there was a previous attempt to create a “health DARPA” during the Trump administration in late 2019. Biden began to promote the idea during his presidential campaign as early as June 2019, albeit using a very different justification for the agency than what had been pitched by its advocates to Trump. In 2019, the same foundation and individuals currently backing Biden’s ARPA-H had urged then president Trump to create “HARPA,” not for the main purpose of researching treatments for cancer and Alzheimer’s, but to stop mass shootings before they happen through the monitoring of Americans for “neuropsychiatric” warning signs.
For the last few years, one man has been the driving force behind HARPA—former vice chair of General Electric and former president of NBCUniversal, Robert Wright. Through the Suzanne Wright Foundation (named for his late wife), Wright has spent years lobbying for an agency that “would develop biomedical capabilities—detection tools, treatments, medical devices, cures, etc.—for the millions of Americans who are not benefitting from the current system.” While he, like Biden, has cloaked the agency’s actual purpose by claiming it will be mainly focused on treating cancer, Wright’s 2019 proposal to his personal friend Donald Trump revealed its underlying ambitions.
As first proposed by Wright in 2019, the flagship program of HARPA would be SAFE HOME, short for Stopping Aberrant Fatal Events by Helping Overcome Mental Extremes. SAFE HOME would suck up masses of private data from “Apple Watches, Fitbits, Amazon Echo, and Google Home” and other consumer electronic devices, as well as information from health-care providers to determine if an individual might be likely to commit a crime. The data would be analyzed by artificial intelligence (AI) algorithms “for early diagnosis of neuropsychiatric violence.”
The Department of Justice’s pre-crime approach known as DEEP was activated just months before Trump left office; it was also justified as a way to “stop mass shootings before they happen.” Soon after Biden’s inauguration, the new administration began using information from social media to make pre-crime arrests as part of its approach toward combatting “domestic terror.” Given the history of Silicon Valley companies collaborating with the government on matters of warrantless surveillance, it appears that aspects of SAFE HOME may already be covertly active under Biden, only waiting for the formalization of ARPA-H/HARPA to be legitimized as public policy.
The national-security applications of Robert Wright’s HARPA are also illustrated by the man who was its lead scientific adviser—former head of DARPA’s Biological Technologies Office Geoffrey Ling. Not only is Ling the main scientific adviser of HARPA, but the original proposal by Wright would have Ling both personally design HARPA and lead it once it was established. Ling’s work at DARPA can be summarized by BTO’s stated mission, which is to work toward merging “biology, engineering, and computer science to harness the power of natural systems for national security.” BTO-favored technologies are also poised to be the mainstays of HARPA, which plans to specifically use “advancements in biotechnology, supercomputing, big data, and artificial intelligence” to accomplish its goals.
The direct DARPA connection to HARPA underscores that the agenda behind this coming agency dates back to the failed Bio-Surveillance project of DARPA’s Total Information Awareness program, which was launched after the events of September 11, 2001. TIA’s Bio-Surveillance project sought to develop the “necessary information technologies and resulting prototype capable of detecting the covert release of a biological pathogen automatically, and significantly earlier than traditional approaches,” accomplishing this “by monitoring non-traditional data sources” including “pre-diagnostic medical data” and “behavioral indicators.”
While nominally focused on “bioterrorist attacks,” TIA’s Bio-Surveillance project also sought to acquire early detection capabilities for “normal” disease outbreaks. Bio-Surveillance and related DARPA projects at the time, such as LifeLog, sought to harvest data through the mass use of some sort of wearable or handheld technology. These DARPA programs were ultimately shut down due to the controversy over claims they would be used to profile domestic dissidents and eliminate privacy for all Americans in the US.
That DARPA’s past total surveillance dragnet is coming back to life under a supposedly separate health-focused agency, and one that emulates its organizational model no less, confirms that many TIA-related programs were merely distanced from the Department of Defense when officially shut down. By separating the military from the public image of such technologies and programs, it made them more palatable to the masses, despite the military remaining heavily involved behind the scenes. As Unlimited Hangout has recently reported, major aspects of TIA were merely privatized, giving rise to companies such as Facebook and Palantir, which resulted in such DARPA projects being widely used and accepted. Now, under the guise of the proposed ARPA-H, DARPA’s original TIA would essentially be making a comeback for all intents and purposes as its own spin-off.
Silicon Valley, the Military and the Wearable “Revolution”
This most recent effort to create ARPA-H/HARPA combines well with the coordinated push of Silicon Valley companies into the field of health care, specifically Silicon Valley companies that double as contractors to US intelligence and/or the military (e.g., Microsoft, Google, and Amazon). During the COVID-19 crisis, this trend toward Silicon Valley dominance of the health-care sector has accelerated considerably due to a top-down push toward digitalization with telemedicine, remote monitoring, and the like.
One interesting example is Amazon, which launched a wearable last year that purports to not only use biometrics to monitor people’s physical health and fitness but to track their emotional state as well. The previous year, Amazon acquired the online pharmacy PillPack, and it is not hard to imagine a scenario in which data from Amazon’s Halo wellness band is used to offer treatment recommendations that are then supplied by Amazon-owned PillPack.
Companies such as Amazon, Palantir, and Google are set to be intimately involved in ARPA-H’s activities. In particular, Google, which launched numerous health-tech initiatives in 2020, is set to have a major role in this new agency due to its long-standing ties to the Obama administration when Biden was vice president and to President Biden’s top science adviser, Eric Lander.
As mentioned, Lander is poised to play a major role in ARPA-H/HARPA if and when it materializes. Before becoming the top scientist in the country, Lander was president and founding director of the Broad Institute. While advertised as a partnership between MIT and Harvard, the Broad Institute is heavily influenced by Silicon Valley, with two former Google executives on its board, a partner of Silicon Valley venture capital firm Greylock Partners, and the former CEO of IBM, as well as some of its top endowments coming from prominent tech executives.
Former Google CEO Eric Schmidt, who was intimately involved with Obama’s 2012 reelection campaign and who is close to the Democratic Party in general, chairs the Broad Institute as of this April. In March, Schmidt gave the institute $150 million to “connect biology and machine learning for understanding programs of life.” During his time on the Broad Institute board, Schmidt also chaired the National Security Commission on Artificial Intelligence, a group of mostly Silicon Valley, intelligence, and military operatives who have now charted the direction of the US government’s policies on emerging tech and AI. Schmidt was also pitched as potential head of a tech-industry task force by the Biden administration.
Earlier, in January, the Broad Institute announced that its health-research platform, Terra, which was built with Google subsidiary Verily, would partner with Microsoft. As a result, Terra now allows Google and Microsoft to access a vast trove of genomic data that is poured into the platform by academics and research institutions from around the world.
In addition, last September, Google teamed up with the Department of Defense as part of a new AI-driven “predictive health” program that also has links to the US intelligence community. While initially focused on predicting cancer cases, this initiative clearly plans to expand to predicting the onset of other diseases before symptoms appear, including COVID-19. As noted by Unlimited Hangout at the time, one of the ulterior motives for the program, from Google’s perspective, was for Google to gain access to “the largest repository of disease- and cancer-related medical data in the world,” which is held by the Defense Health Agency. Having exclusive access to this data is a huge boon for Google in its effort to develop and expand its growing suite of AI health-care products.
The military is currently being used to pilot COVID-19–related biometric wearables for “returning to work safely.” Last December, it was announced that Hill Air Force Base in Utah would make biometric wearables a mandatory part of the uniform for some squadrons. For example, the airmen of the Air Force’s 649th Munitions Squadron must now wear a smart watch made by Garmin and a smart ring made by Oura as part of their uniform.
According to the Air Force, these devices detect biometric indicators that are then analyzed for 165 different biomarkers by the Defense Threat Reduction Agency/Philips Healthcare AI algorithm that “attempts to recognize an infection or virus around 48 hours before the onset of symptoms.” The development of that algorithm began well before the COVID-19 crisis and is a recent iteration of a series of military research projects that appear to have begun under the 2007 DARPA Predicting Health and Disease (PHD) project.
While of interest to the military, these wearables are primarily intended for mass use—a big step toward the infrastructure needed for the resurrection of a bio-surveillance program to be run by the national-security state. Starting first with the military makes sense from the national-security apparatus’s perspective, as the ability to monitor biometric data, including emotions, has obvious appeal for those managing the recently expanded “insider threat” programs in the military and the Department of Homeland Security.
One indicator of the push for mass use is that the same Oura smart ring being used by the Air Force was also recently utilized by the NBA to prevent COVID-19 outbreaks among basketball players. Prior to COVID-19, it was promoted for consumer use by members of the British Royal family and Twitter CEO Jack Dorsey for improving sleep. As recently as last Monday, Oura’s CEO, Harpeet Rai, said that the entire future of wearable health tech will soon be “proactive rather than reactive” because it will focus on predicting disease based on biometric data obtained from wearables in real time.
Another wearable tied to the military that is creeping into mass use is the BioButton and its predecessor the BioSticker. Produced by the company BioIntelliSense, the sleek new BioButton is advertised as a wearable system that is “a scalable and cost-effective solution for COVID-19 symptom monitoring at school, home and work.” BioIntelliSense received $2.8 million from the Pentagon last December to develop the BioButton and BioSticker wearables for COVID-19.
BioIntelliSense, cofounded and led by former Microsoft HealthVault developer James Mault, now has its wearable sensors being rolled out for widespread use on some college campuses and at some US hospitals. In some of those instances, the company’s wearables are being used to specifically monitor the side effects of the COVID-19 vaccine as opposed to symptoms of COVID-19 itself. BioIntelliSense is currently running a study, partnered with Philips Healthcare and the University of Colorado, on the use of its wearables for early COVID-19 detection, which is entirely funded by the US military.